Immucell (ICCC) Common Equity (2010 - 2026)
Immucell's Common Equity was $31.37 million in Q2 2026, up 5.0% from $29.87 million a year earlier.
Powered by 
Analysis
Immucell (ICCC) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Immucell came in at $27.06 million, down 1.7% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
- In earlier years, Common Equity was $27.52 million in FY2024 (+10.1%), $24.99 million in FY2023 (-17.7%), $30.38 million in FY2022 (-6.7%) and $32.58 million in FY2021 (+15.3%).
- The Q2 2026 figure marks the highest quarterly Common Equity since Q3 2022.
- Compared with a year earlier, Common Equity was higher in six of the last seven quarters, with growth averaging 10.4%.
- The best year-over-year quarter for Common Equity over five years was Q2 2025 (growth of 27.3%); the worst was Q3 2023 (a decline of 18.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | 31.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.37 Mn |
| Dec 31, 2025 | 27.06 Mn |
| Sep 30, 2025 | 29.80 Mn |
| Jun 30, 2025 | 29.87 Mn |
| Mar 31, 2025 | 28.99 Mn |
| Dec 31, 2024 | 27.52 Mn |
| Sep 30, 2024 | 26.41 Mn |
| Jun 30, 2024 | 23.46 Mn |
| Mar 31, 2024 | 24.64 Mn |
| Dec 31, 2023 | 24.99 Mn |
| Sep 30, 2023 | 26.01 Mn |
| Jun 30, 2023 | 26.86 Mn |
| Mar 31, 2023 | 28.16 Mn |
| Dec 31, 2022 | 30.38 Mn |
| Sep 30, 2022 | 31.98 Mn |
| Jun 30, 2022 | 32.55 Mn |
| Mar 31, 2022 | 33.15 Mn |
| Dec 31, 2021 | 32.58 Mn |
| Sep 30, 2021 | 32.46 Mn |
| Jun 30, 2021 | 32.27 Mn |
API Access
Immucell Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();